Currently, there are 608.35M common shares owned by the public and among those 601.89M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -6.96% and -16.79% over the past three months. OWL shares are trading -14.96% year to date (YTD), with the 12-month market performance up to 10.13% higher. It has a 12-month low price of $15.18 and touched a high of $26.73 over the same period. OWL has an average intraday trading volume of 6.18 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -13.53%, -16.23%, and -4.36% respectively.
Institutional ownership of Blue Owl Capital Inc (NYSE: OWL) shares accounts for 93.19% of the company’s 608.35M shares outstanding.
It has a market capitalization of $29.70B and a beta (3y monthly) value of 1.19. The stock’s trailing 12-month PE ratio is 134.65, while the earnings-per-share (ttm) stands at $0.15. The company has a PEG of 7.60 and a Quick Ratio of 1.19 with the debt-to-equity ratio at 1.40. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.65% over the week and 4.15% over the month.
Earnings per share for the fiscal year are expected to increase by 18.98%, and 20.77% over the next financial year.
Looking at the support for the OWL, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on February 24, 2025, with the firm’s price target at $29. Citigroup coverage for the Blue Owl Capital Inc (OWL) stock in a research note released on January 23, 2025 offered a Buy rating with a price target of $30. TD Cowen was of a view on January 16, 2025 that the stock is Buy, while Goldman gave the stock Neutral rating on January 06, 2025, issuing a price target of $25- $24.75. Wells Fargo on their part issued Equal Weight rating on September 12, 2024.
